Abstract
Overview
Introduction
This analysis examines the historical and forecast performance for Menarini in
the ethical pharmaceutical sector. The profile encompasses global company
strategy, portfolio and pipeline analysis and assessment of financial
performance, with 1-6 year sales forecasts for key drugs. An interactive
forecasting and analysis tool provides continually updated quantitative and
qualitative information.
Reasons to Purchase
- Benchmark Menarini' s performance against key rivals in the ethical
pharmaceutical sector
- See how Menarini will achieve relatively low growth as the small gains
made by some products are counteracted by the small losses felt by others
- Learn how despite the launch of its first major internally discovered
product, amediplase, the company will remain heavily reliant on externalization
View Cart
